• DiscoveryProbe FDA-approved Drug Library for GPCRs

  2026-08-11

  The DiscoveryProbe FDA-approved Drug Library enables mechanism-led GPCR profiling, combining broad pharmacology with practical assay-design guidance. Learn how iterative screening and orthogonal validation can convert phenotypic hits into credible pharmacological probes.

• ω-Agatoxin IVA Suppresses Epileptogenesis

  2026-08-11

  This rat study identifies selective P/Q-type Cav2.1 calcium-channel blockade with ω-agatoxin IVA as a strategy for suppressing chemical kindling, epileptic discharges, and apoptosis-associated changes. By combining seizure behavior, freely moving EEG, motor testing, and regional immunohistochemistry, the work links Cav2.1 activity with both epileptogenesis and neurobiological responses involving BDNF and cleaved caspase-3.

• BQCA Workflows for M1 Receptor Signaling

  2026-08-10

  Benzyl Quinolone Carboxylic Acid (BQCA) enables selective interrogation of M1 muscarinic receptor potentiation, from ACh dose-response assays to BRET-based studies of GRK-dependent signaling bias. This practical guide connects assay design, brain-relevant readouts, compound handling, and troubleshooting for cognitive function modulation and Alzheimer’s disease research.

• Dacarbazine: From DNA Damage to CINV

  2026-08-09

  Dacarbazine is an antineoplastic chemotherapy drug whose clinical value depends on both tumor-cell DNA damage and effective supportive care. This evidence-led guide connects its chemistry, assay interpretation, and chemotherapy-induced nausea and vomiting prevention without repeating conventional workflow reviews.

• HyperPFU™ high-fidelity DNA polymerase Guide

  2026-08-08

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate PCR amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is appropriate for blunt-ended products used in cloning and sequencing, but not for workflows that require 3′-A overhangs or polymerase-generated sticky ends.

• Ertugliflozin PF-04971729: From Target to Phenotype

  2026-08-07

  Explore how Ertugliflozin (PF-04971729) connects SGLT2 target engagement with renal, cardiovascular, and intestinal research outcomes. This translational framework helps investigators select orthogonal assays and interpret clinical evidence without conflating molecular selectivity with therapeutic ranking.

• HyperScribe All in One mRNA Synthesis Kit Plus 1: Applied In

  2026-08-07

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 streamlines ARCA-capped, immune-evasive mRNA production for RNA vaccine development, RNAi, and functional genomics. Explore experimental workflows, troubleshooting strategies, and practical insights informed by translational research and recent breakthroughs in mRNA vaccine science.

• Danazol: Mechanistic Insights and Strategic Use in Translati

  2026-08-06

  This article delivers a thought-leadership perspective on Danazol (Danocrine), integrating mechanistic detail and workflow strategy for translational researchers. We explore Danazol’s role in androgen receptor signaling, inhibition of steroidogenesis, and endocrine disease modeling—highlighting evidence from recent precocious puberty and prostate cancer studies. The article guides experimental design, protocol optimization, and competitive positioning, emphasizing APExBIO’s high-purity offering to ensure reproducibility and translational value.

• Comparative Cardiovascular Efficacy of SGLT2 Inhibitors in T

  2026-08-06

  This systematic review and network meta-analysis rigorously compares the cardiovascular benefits of individual SGLT2 inhibitors, including Ertugliflozin (PF-04971729), in patients with type 2 diabetes and heart failure. The findings clarify relative efficacy profiles and inform optimal compound selection for both clinical and translational research.

• LC–MS/MS Reveals Oral Prodrug Pathways of GS-441524 In Vivo

  2026-08-05

  This study introduces a validated LC–MS/MS approach to elucidate the metabolic conversion of a novel GS-441524 prodrug (NGP-1) into its active antiviral form, mapping absorption and distribution in vitro and in vivo. The findings support prodrug design for improved oral bioavailability and inform translational strategies for anti-SARS-CoV-2 nucleoside analogs.

• DiscoveryProbe FDA-approved Drug Library: Applied Screening

  2026-08-05

  Unlock robust drug repositioning and target identification with the DiscoveryProbe FDA-approved Drug Library. This collection streamlines high-throughput workflows and empowers advanced screening strategies, as evidenced by recent breakthroughs in dual-mode antiviral assays.

• Optimizing Cell Assays with Fasudil (HA-1077) HCl: Best Prac

  2026-08-04

  This article provides scenario-driven guidance for leveraging Fasudil (HA-1077) HCl (SKU A5734) in cell viability, proliferation, and cytotoxicity assays. Drawing from evidence-based laboratory challenges, we show how this selective ROCK inhibitor ensures reproducible results and robust pathway targeting. Practical protocol parameters and vendor selection insights are included for bench scientists.

• Balsalazide Disodium Dihydrate: Precision Tools for Translat

  2026-08-04

  This thought-leadership article explores how Balsalazide Disodium Dihydrate, a water-soluble 5-aminosalicylic acid prodrug, empowers translational researchers to interrogate inflammation mechanisms and optimize IBD modeling. We synthesize mechanistic insights, recent radioiodination breakthroughs, and strategic recommendations for integrating this compound into advanced immunology and imaging workflows. By bridging evidence from foundational studies and real-world protocols, we offer actionable guidance and visionary perspectives for researchers seeking high-fidelity, clinically relevant outcomes.

• Dasatinib Monohydrate in 3D Tumor Models: Protocols & Insigh

  2026-08-03

  Dasatinib Monohydrate (BMS-354825) delivers robust kinase inhibition, making it indispensable for dissecting resistance in complex preclinical cancer models. This guide translates breakthrough assembloid workflows into actionable steps and troubleshooting advice for researchers tackling imatinib-resistant and microenvironment-driven drug response.

• Mouse Neutrophil Cell Isolation Kit: Precision for Immunothe

  2026-08-03

  Unlock the full potential of high-purity neutrophil isolation with the Mouse Neutrophil Cell Isolation Kit. This in-depth review reveals the scientific foundations and translational impact of negative selection, with advanced assay considerations for next-generation immunotherapy.

15968 records 1/1065 page Next 12345 下5页 Last page